(MINNEAPOLIS, Minn.) January 29, 2024 – Fasikl, a Minnesota-based neuro-AI company, announces the completion of two prospective studies for their Felix™ NeuroAI™ Wristband, a wearable technology specifically engineered to offer all-day relief from tremors for adults suffering from a condition known as essential tremor. Results from the studies simultaneously conducted in the United States (US) and […]

Posted on January 8, 2024

BOSTON and SHANGHAI, Jan. 05, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced an exclusive collaboration and license agreement with Tenacia Biotechnology (Shanghai) Company, Ltd., a China-based clinical-stage biopharmaceutical […]

MIAMI, Oct. 16, 2023 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it has been awarded the 2023 BioFlorida David J. Gury Company of the Year Award for distinguished achievement in focused ultrasound technology and contributions to Florida’s life sciences industry. The award was presented at BioFlorida’s 26th Annual […]

Posted on October 4, 2023

BOSTON, Oct. 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today provided an update on its clinical portfolio at the company’s R&D Day. Praxis’ leaders were joined by two esteemed […]

Posted on June 14, 2023

June 14, 2023 – Cala announced today that it launched its next-generation Cala kIQ system, a wearable device that delivers therapy for neurological disorders. The San Mateo, California-based company develops the Cala Trio device for transcutaneous afferent patterned stimulation (TAPS) therapy. Cala designed the Trio device for treating tremor. Its kIQ system delivers therapy for action […]

Posted on March 20, 2023

Praxis Precision Medicines has reported topline data from the Phase IIb Essential1 trial of ulixacaltamide (PRAX-944) to treat essential tremor (ET). The placebo-controlled, randomised, dose range finding, double-blind trial has been designed for assessing the safety, tolerability, and efficacy of once-a-day 60mg or 100mg ulixacaltamide treatment against a placebo after 56 days.

Posted on August 25, 2022

The International Essential Tremor Foundation will bring together experts, scientists, patients, and family members for a day of learning about essential tremor.  Lenexa, Kansas – The first ever Essential Tremor Virtual Education Conference will take place Saturday, October, 29, 2022, from 9 AM to 1 PM (CST). Hosted by the International Essential Tremor Foundation (IETF), […]

Posted on March 1, 2022

BURLINGAME, CA — March 1, 2022 — Cala Health, the bioelectronic medicine leader setting a newstandard of patient care for chronic disease, closed 2021 with significant reimbursement accomplishments for patients. New coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment […]

Categories: ET News, In the News
Posted on March 25, 2021

(Nature Neuroscience, March 18, 2021) Cannabinoids reduce tremor associated with motor disorders induced by injuries and neurodegenerative disease. Here we show that this effect is mediated by cannabinoid receptors on astrocytes in the ventral horn of the spinal cord, where alternating limb movements are initiated. We first demonstrate that tremor is reduced in a mouse […]

Shaky hands are not a sign of aging. And a shaky head is not a sure sign of Parkinson’s disease. An involuntary shaking of the hands, head, voice, legs or trunk can be a sign of essential tremor (ET). ET is one of the most common movement disorders in the world, and the most common […]

Categories: ET Awareness, ET News